Memorial Sloan Kettering (MSK) Cancer Center’s Senior Director of Clinical Research Informatics and Technology, Joe Lengfellner, tells us how MSK validated and scaled EHR-to-EDC technology across MSK’s vast portfolio of trials.
Editorial by Category
Modernizing Clinical Trial Operations
View All
How Power, DPHARM Idol 2024, Is Building the AI Platform for Central Patient Recruitment
Rethinking Study Startup with Novel Technology for Site-Sponsor Collaboration
How Parexel is Solving for Site Issues in Payment, Technology, and Redundancy
Expanding Access and Accelerating Cancer Drug Development through Community-Based Oncology Research
Immuno-Oncology and Cell Therapy
View All
Whole-Body Molecular Imaging’s Impact on Understanding Tumor Response and Advancing Immuno-Oncology (IO) Drug Development
Going After Immune Resistance and Metastases in Cancer Using RNA-Based Therapeutics
Staying Passionate about IO’s Potential and Investing in Biotechs Addressing IO’s Toughest Challenges
GSK’s Head of Precision Medicine on Biomarker Focus and the Use of Next-Generation Technologies
Drug Delivery
View All
De-risking Combination Product Development Through Early Data-Driven Evaluation of Container Closure Systems
Micronization and Milling: A Strategic Tool to Enhance Drug Development and Manufacturing
Leading Drug Delivery Conference PODD Announces its 15th Annual Agenda
How Genentech’s Approach to Partnership and Licensing is Driving Innovation
Patients as Partners in Clinical Research and Patient Access
View All
Operationalizing a New R&D Patient-Centricity Model at J&J
Involving Patient Insights in Medicine Development to Better Support Access and Decision-Making: Patients as Partners Europe 2025 Recap
How Pfizer Is Tackling Patient Insight Continuity Across a Global Organization
7 Key Takeaways of the Novo Nordisk Rare Disease Survey in Sickle Cell Disease from Patients as Partners 2025
Biotech CMO/R&D Leadership
View All
CRAACO: Clinical Research as a Care Option
View All
How Dana-Farber Makes Clinical Trials Fit-For-Purpose in the Community Clinic Setting
How to Use Patient-Reported Outcomes to Bring Better Drugs Forward for Patients
Expanding Access and Accelerating Cancer Drug Development through Community-Based Oncology Research
How Sponsors Can Help Sites with Payment, Staffing and Technology
Women Leadership in Biotech
View All
The Conference Forum Sees Record Growth in Attendees Across 2024 Events, Bringing Together Leaders in Medicine Development
Women Leadership in Immuno-Oncology: 2022 Celebration Series
Women Leadership in Immuno-Oncology: 2021 Celebration Series
